Invention Grant
- Patent Title: Pharmaceutical solution formulations for pressurised metered dose inhalers
-
Application No.: US15353978Application Date: 2016-11-17
-
Publication No.: US10525006B2Publication Date: 2020-01-07
- Inventor: David Andrew Lewis , Brian John Meakin , Gaetano Brambilla
- Applicant: CHIESI FARMACEUTICI S.P.A.
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.P.A.
- Current Assignee: CHIESI FARMACEUTICI S.P.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/167 ; A61K31/58 ; A61K47/10 ; A61K9/12 ; A61K31/138 ; A61K31/4745 ; A61K31/57 ; A61K31/573 ; A61K45/06 ; A61K31/4704
Abstract:
The invention relates to the prevention and/or treatment of a severe broncho-pulmonary disease by administering a solution formulation from a pressurized metered dose inhaler capable of providing therapeutical doses of two or more active drug substances to the lung, wherein all the active drug substances are fully dissolved in the formulation as well as the two or more active drug substances are delivered with substantially the same particle size distribution.
Public/Granted literature
- US20170065518A1 PHARMACEUTICAL SOLUTION FORMULATIONS FOR PRESSURISED METERED DOSE INHALERS Public/Granted day:2017-03-09
Information query
